Florida Senate Bill 172 Action Alert

Florida Senate Bill 172 Action Alert

SB172 is on the agenda of the Senate Innovation, Industry and Technology Committee meeting on Monday, November 4.

Bill                       Sponsor              Title     

SB 172               Bradley               Florida Drug and Cosmetic Act

Preempts the regulation of over-the-counter proprietary drugs or cosmetics to the state.  Preemption by the state precludes residents from enacting public policy initiatives that address issues of concern in their local communities.

Recent studies have found that sunscreen chemicals oxybenzone and octinoxate damage corals.  Healthy coral reefs are significant tourist attractions to many Florida coastal communities.

Contact your Senator by email or phone and urge him or her to oppose this bill.  You can also text the word ‘State’ on Messenger, Twitter, Telegram, or to 50409 on SMS.  Include your name, ZIP code and contact information in your message.

District          Senate Innovation, Industry and Technology Committee

5      Rob Bradley                bradley.rob.web@flsenate.gov                  (850) 487-5005    

6      Audrey Gibson           gibson.audrey.web@flsenate.gov              (850) 487-5006    

7      Travis Hutson            hutson.travis.web@flsenate.gov                 (850) 487-5007    

10   Wilton Simpson        simpson.wilton.web@flsenate.gov             (850) 487-5010   Chair

11    Randolph Bracy        bracy.randolph.web@flsenate.gov             (850) 487-5011     

24   Jeff Brandes               brandes.jeff.web@flsenate.gov                  (850) 487-5024    

27  Lizbeth Benacquisto  benacquisto.lizbeth.web@flsenate.gov      (850) 487-5027    

28  Kathleen Passidomo  passidomo.kathleen.web@flsenate.gov    (850) 487-5028    

34    Gary Farmer             farmer.gary.web@flsenate.gov                   (850) 487-5034    

35    Oscar Braynon         braynon.oscar.web@flsenate.gov              (850) 487-5035    

Was this Action Alert forwarded to you? Join our mailing list! Sign up here